315 related articles for article (PubMed ID: 17052815)
1. LC16m8: an attenuated smallpox vaccine.
Kenner J; Cameron F; Empig C; Jobes DV; Gurwith M
Vaccine; 2006 Nov; 24(47-48):7009-22. PubMed ID: 17052815
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the study of live attenuated cell-cultured smallpox vaccine LC16m8.
Eto A; Saito T; Yokote H; Kurane I; Kanatani Y
Vaccine; 2015 Nov; 33(45):6106-11. PubMed ID: 26319072
[TBL] [Abstract][Full Text] [Related]
3. Vaccinia virus strain LC16m8 defective in the B5R gene keeps strong protection comparable to its parental strain Lister in immunodeficient mice.
Yokote H; Shinmura Y; Kanehara T; Maruno S; Kuranaga M; Matsui H; Hashizume S
Vaccine; 2015 Nov; 33(45):6112-9. PubMed ID: 26241947
[TBL] [Abstract][Full Text] [Related]
4. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.
Kennedy JS; Gurwith M; Dekker CL; Frey SE; Edwards KM; Kenner J; Lock M; Empig C; Morikawa S; Saijo M; Yokote H; Karem K; Damon I; Perlroth M; Greenberg RN
J Infect Dis; 2011 Nov; 204(9):1395-402. PubMed ID: 21921208
[TBL] [Abstract][Full Text] [Related]
5. Freeze-dried live attenuated smallpox vaccine prepared in cell culture "LC16-KAKETSUKEN": Post-marketing surveillance study on safety and efficacy compliant with Good Clinical Practice.
Nishiyama Y; Fujii T; Kanatani Y; Shinmura Y; Yokote H; Hashizume S
Vaccine; 2015 Nov; 33(45):6120-7. PubMed ID: 26455406
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8.
Saito T; Fujii T; Kanatani Y; Saijo M; Morikawa S; Yokote H; Takeuchi T; Kuwabara N
JAMA; 2009 Mar; 301(10):1025-33. PubMed ID: 19278946
[TBL] [Abstract][Full Text] [Related]
7. Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge.
Empig C; Kenner JR; Perret-Gentil M; Youree BE; Bell E; Chen A; Gurwith M; Higgins K; Lock M; Rice AD; Schriewer J; Sinangil F; White E; Buller RM; Dermody TS; Isaacs SN; Moyer RW
Vaccine; 2006 Apr; 24(17):3686-94. PubMed ID: 16430997
[TBL] [Abstract][Full Text] [Related]
8. Profiling of the antibody response to attenuated LC16m8 smallpox vaccine using protein array analysis.
Eto A; Fujita M; Nishiyama Y; Saito T; Molina DM; Morikawa S; Saijo M; Shinmura Y; Kanatani Y
Vaccine; 2019 Oct; 37(44):6588-6593. PubMed ID: 31540810
[TBL] [Abstract][Full Text] [Related]
9. New generation smallpox vaccines: a review of preclinical and clinical data.
Artenstein AW
Rev Med Virol; 2008; 18(4):217-31. PubMed ID: 18283712
[TBL] [Abstract][Full Text] [Related]
10. An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection.
Morikawa S; Sakiyama T; Hasegawa H; Saijo M; Maeda A; Kurane I; Maeno G; Kimura J; Hirama C; Yoshida T; Asahi-Ozaki Y; Sata T; Kurata T; Kojima A
J Virol; 2005 Sep; 79(18):11873-91. PubMed ID: 16140764
[TBL] [Abstract][Full Text] [Related]
11. Serological responses in humans to the smallpox vaccine LC16m8.
Johnson BF; Kanatani Y; Fujii T; Saito T; Yokote H; Smith GL
J Gen Virol; 2011 Oct; 92(Pt 10):2405-2410. PubMed ID: 21715598
[TBL] [Abstract][Full Text] [Related]
12. A Single Vaccination of Nonhuman Primates with Highly Attenuated Smallpox Vaccine, LC16m8, Provides Long-term Protection against Monkeypox.
Iizuka I; Ami Y; Suzaki Y; Nagata N; Fukushi S; Ogata M; Morikawa S; Hasegawa H; Mizuguchi M; Kurane I; Saijo M
Jpn J Infect Dis; 2017 Jul; 70(4):408-415. PubMed ID: 28003603
[TBL] [Abstract][Full Text] [Related]
13. LC16m8, a highly attenuated vaccinia virus vaccine lacking expression of the membrane protein B5R, protects monkeys from monkeypox.
Saijo M; Ami Y; Suzaki Y; Nagata N; Iwata N; Hasegawa H; Ogata M; Fukushi S; Mizutani T; Sata T; Kurata T; Kurane I; Morikawa S
J Virol; 2006 Jun; 80(11):5179-88. PubMed ID: 16698998
[TBL] [Abstract][Full Text] [Related]
14. Safety of attenuated smallpox vaccine LC16m8 in immunodeficient mice.
Yokote H; Shinmura Y; Kanehara T; Maruno S; Kuranaga M; Matsui H; Hashizume S
Clin Vaccine Immunol; 2014 Sep; 21(9):1261-6. PubMed ID: 24990910
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of the immune responses and protection engendered by LC16m8 and Dryvax smallpox vaccines in a mouse model.
Meseda CA; Mayer AE; Kumar A; Garcia AD; Campbell J; Listrani P; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
Clin Vaccine Immunol; 2009 Sep; 16(9):1261-71. PubMed ID: 19605597
[TBL] [Abstract][Full Text] [Related]
16. Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8.
Kidokoro M; Tashiro M; Shida H
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4152-7. PubMed ID: 15753319
[TBL] [Abstract][Full Text] [Related]
17. Safety and Immunogenicity of LC16m8, an Attenuated Smallpox Vaccine in Vaccinia-Naive Adults.
Friedman D
J Infect Dis; 2012 Oct; 206(7):1149; author reply 1149-50. PubMed ID: 22829644
[No Abstract] [Full Text] [Related]
18. Smallpox vaccines for biodefense: need and feasibility.
Artenstein AW; Grabenstein JD
Expert Rev Vaccines; 2008 Oct; 7(8):1225-37. PubMed ID: 18844596
[TBL] [Abstract][Full Text] [Related]
19. Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.
Pittman PR; Hahn M; Lee HS; Koca C; Samy N; Schmidt D; Hornung J; Weidenthaler H; Heery CR; Meyer TPH; Silbernagl G; Maclennan J; Chaplin P
N Engl J Med; 2019 Nov; 381(20):1897-1908. PubMed ID: 31722150
[TBL] [Abstract][Full Text] [Related]
20. Smallpox vaccine: problems and prospects.
Poland GA; Neff JM
Immunol Allergy Clin North Am; 2003 Nov; 23(4):731-43. PubMed ID: 14753389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
